Hi BT & yes we didn’t get any safety signals there in critically unwell patients (ICU admissions), but the ARB/ACEi arm was stopped in a global COVID platform trial. The other thing is that DMX-200 could be useful in pneumonia & ILD (interstitial lung disease). It wasn’t our IP that stopped this arm on safety signals, so for sure at the time, incredibly disappointing for us, but all the data adds up. The FDA must like it anyway to allow kids on the trial come March 2024.
DXB Media thread., page-12
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
64.5¢ |
Change
0.065(11.2%) |
Mkt cap ! $354.5M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 65.0¢ | 58.0¢ | $3.696M | 5.951M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 64.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 65.0¢ | 109360 | 4 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
64.5¢ |
Change
0.065 ( 12.4 %) |
||||
| Open | High | Low | Volume | ||
| 59.0¢ | 65.5¢ | 58.5¢ | 3782284 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| DXB (ASX) Chart |